• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU 0.00% 10.5¢

IMUGENE LIMITED - Announcements

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Announcements


IMU Phase 1 onCARlytics Trial Advances to Combination ArmPRICE SENSITIVE11/03/24 download Created with Sketch. 193.84KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE29/02/24 download Created with Sketch. 1.15MB
IMU Phase 1 onCARlytics Trial Doses First Intravenous PatientPRICE SENSITIVE15/02/24 download Created with Sketch. 192.99KB
IMU Notice of change of interests of substantial holder - PH02/02/24 download Created with Sketch. 179.34KB
IMU Change of Director's Interest Notice - PH01/02/24 download Created with Sketch. 5.05KB
IMU Cleansing Notice01/02/24 download Created with Sketch. 199.71KB
IMU Application for quotation of securities - IMU01/02/24 download Created with Sketch. 26.72KB
IMU Application for quotation of securities - IMU01/02/24 download Created with Sketch. 27.26KB
IMU Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 488.54KB
IMU Change of Director's Interest Notice x619/01/24 download Created with Sketch. 27.4KB
IMU Imugene CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI19/01/24 download Created with Sketch. 191.12KB
IMU VAXINIA Phase 1 trial doses patients in higher dose cohortsPRICE SENSITIVE19/01/24 download Created with Sketch. 239.95KB
IMU Update - Notification regarding unquoted securities - IMU18/01/24 download Created with Sketch. 40.52KB
IMU Phase 1 CF33-hNIS Study Update - Positive Early SignalsPRICE SENSITIVE17/01/24 download Created with Sketch. 181.6KB
IMU Notification regarding unquoted securities - IMU17/01/24 download Created with Sketch. 40.78KB
IMU Imugene Presentation to JPMorgan Healthcare Conference10/01/24 download Created with Sketch. 4.33MB
IMU Imugene and NeoImmuneTech to Improve Cancer TreatmentsPRICE SENSITIVE12/12/23 download Created with Sketch. 193KB
IMU Imugene to Present at Annual JPMorgan Healthcare Conference11/12/23 download Created with Sketch. 164.66KB
IMU Application for quotation of securities - IMU06/12/23 download Created with Sketch. 26.61KB
IMU New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUSPRICE SENSITIVE06/12/23 download Created with Sketch. 176.65KB
IMU Europe Patent to be Granted for PD1-Vaxx Cancer VaccinePRICE SENSITIVE06/12/23 download Created with Sketch. 127.27KB
IMU Results of Meeting30/11/23 download Created with Sketch. 191.12KB
IMU AGM Presentation30/11/23 download Created with Sketch. 3.03MB
IMU FDA Fast Track Designation Granted for VAXINIA Trial ProgramPRICE SENSITIVE28/11/23 download Created with Sketch. 161.6KB
IMU Investor Webinar featuring COO, Dr Glover & CMO, Dr Woodard14/11/23 download Created with Sketch. 119.86KB
IMU Azer-cel Hits Major Milestone in Phase 1b CAR T TrialPRICE SENSITIVE10/11/23 download Created with Sketch. 193.03KB
IMU Imugene Investor Webinar - MAST Study Update07/11/23 download Created with Sketch. 119.17KB
IMU Phase 1 CF33 VAXINIA Study Update - Positive Early SignalsPRICE SENSITIVE06/11/23 download Created with Sketch. 179.05KB
IMU Next cohort reached in IV arms of CF33-hNIS (VAXINIA) studyPRICE SENSITIVE02/11/23 download Created with Sketch. 174.52KB
IMU Amended Annual Report31/10/23 download Created with Sketch. 4.19MB
IMU Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 488.42KB
IMU Notice of Annual General Meeting/Proxy Form30/10/23 download Created with Sketch. 1.05MB
IMU Imugene Phase 1 onCARlytics CD19 virus clinical trial opensPRICE SENSITIVE26/10/23 download Created with Sketch. 148.52KB
IMU Imugene B Cell & OV Platforms Featured at ESMO CongressPRICE SENSITIVE24/10/23 download Created with Sketch. 172.35KB
IMU Change of Director's Interest Notice - PH12/10/23 download Created with Sketch. 5.59KB
IMU Change of Director's Interest Notice - LC11/10/23 download Created with Sketch. 8.39KB
IMU Change of Director's Interest Notice - PH04/10/23 download Created with Sketch. 5.66KB
IMU Change of Director's Interest Notice - JD04/10/23 download Created with Sketch. 4.65KB
IMU Change of Director's Interest Notice - JE04/10/23 download Created with Sketch. 4.71KB
IMU Change of Director's Interest Notice - KD04/10/23 download Created with Sketch. 4.27KB
IMU Change of Director's Interest Notice - LR04/10/23 download Created with Sketch. 4.71KB
IMU Change of Director's Interest Notice - LC04/10/23 download Created with Sketch. 4.79KB
IMU Cleansing Notice03/10/23 download Created with Sketch. 198.28KB
IMU Application for quotation of securities - IMU03/10/23 download Created with Sketch. 26.47KB
IMU Distribution Schedule and Top 2003/10/23 download Created with Sketch. 232.36KB
IMU Application for quotation of securities - IMU03/10/23 download Created with Sketch. 30.05KB
IMU Imugene ESG Report 202329/09/23 download Created with Sketch. 1.4MB
IMU Appendix 4G29/09/23 download Created with Sketch. 203.81KB
IMU Corporate Governance Statement 202329/09/23 download Created with Sketch. 1002.39KB
IMU Preliminary Final Report - Reporting Adjustments29/09/23 download Created with Sketch. 146.96KB
IMU Annual Report to shareholders29/09/23 download Created with Sketch. 4.01MB
IMU Results of Extraordinary General Meeting28/09/23 download Created with Sketch. 176.29KB
IMU CEO Presentation to the EGM28/09/23 download Created with Sketch. 1.39MB
IMU Azer-cel FDA IND Transferred to ImugenePRICE SENSITIVE28/09/23 download Created with Sketch. 148.99KB
IMU Application for quotation of securities - IMU26/09/23 download Created with Sketch. 26.59KB
IMU Imugene Closes SPP Raising $18.2 millionPRICE SENSITIVE25/09/23 download Created with Sketch. 118.78KB
IMU Share Purchase Plan Closing Date Extended13/09/23 download Created with Sketch. 148.3KB
IMU Imugene PD1-Vaxx UpdatePRICE SENSITIVE12/09/23 download Created with Sketch. 137.53KB
IMU Imugene Receives Positive Feedback From FDAPRICE SENSITIVE11/09/23 download Created with Sketch. 170.25KB
IMU Paul Woodard, M.D. appointed as Chief Medical Officer04/09/23 download Created with Sketch. 123.19KB
IMU VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1PRICE SENSITIVE04/09/23 download Created with Sketch. 156.91KB
IMU S&P DJI Announces September 2023 Quarterly RebalancePRICE SENSITIVE01/09/23 download Created with Sketch. 121.59KB
IMU Imugene Appoints Dr John Byon as SVP Clinical Development01/09/23 download Created with Sketch. 121.55KB
IMU Notice of Extraordinary General Meeting/Proxy Form30/08/23 download Created with Sketch. 1.16MB
IMU Placement and Share Purchase Plan Update25/08/23 download Created with Sketch. 186.13KB
IMU ProspectusPRICE SENSITIVE25/08/23 download Created with Sketch. 665.61KB
IMU Cleansing Notice25/08/23 download Created with Sketch. 198.28KB
IMU Application for quotation of securities - IMU25/08/23 download Created with Sketch. 26.71KB
IMU Preliminary Final ReportPRICE SENSITIVE25/08/23 download Created with Sketch. 2.27MB
IMU Investor Webinar on Acquisition of License for Azer-cel21/08/23 download Created with Sketch. 119.24KB
IMU Imugene Appoints Dr Bradley Glover as COO21/08/23 download Created with Sketch. 142.33KB
IMU Proposed issue of securities - IMU18/08/23 download Created with Sketch. 32.55KB
IMU Proposed issue of securities - IMU18/08/23 download Created with Sketch. 28.6KB
IMU Imugene Capital Raising PresentationPRICE SENSITIVE18/08/23 download Created with Sketch. 2.05MB
IMU Imugene completes $35M Placement & Launches c.$30M SPPPRICE SENSITIVE18/08/23 download Created with Sketch. 267.71KB
IMU Imugene Licenses Allogeneic CD19 CAR T Cell TherapyPRICE SENSITIVE16/08/23 download Created with Sketch. 178.46KB
IMU Trading HaltPRICE SENSITIVE16/08/23 download Created with Sketch. 211.29KB
IMU Imugene VAXINIA Trial clears Cohort 3 of IT MonotherapyPRICE SENSITIVE14/08/23 download Created with Sketch. 193.5KB
IMU Imugene CF33 Oncolytic Virus Study to be Showcased at SITCPRICE SENSITIVE03/08/23 download Created with Sketch. 134.84KB
IMU Imugene HER-Vaxx and CHECKVacc to be Featured at ESMOPRICE SENSITIVE24/07/23 download Created with Sketch. 142.89KB
IMU Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE21/07/23 download Created with Sketch. 1.4MB
IMU Imugene Corporate Presentation20/07/23 download Created with Sketch. 4.39MB
IMU Imugene and RenovoRx CF33 Virotherapy Delivery CollaborationPRICE SENSITIVE20/07/23 download Created with Sketch. 250.08KB
IMU Imugene Oncolytic Virotherapy CF33 Patent Allowed in the USPRICE SENSITIVE19/07/23 download Created with Sketch. 148.79KB
IMU Imugene Appoints Dr Weitzman Interim Chief Medical Officer18/07/23 download Created with Sketch. 120.71KB
IMU Roadshow investor webinar with Professor Yuman Fong18/07/23 download Created with Sketch. 117.94KB
IMU Final Director's Interest Notice07/07/23 download Created with Sketch. 7.43KB
IMU New Dose Escalation in Phase I Clinical Trial of CHECKvaccPRICE SENSITIVE07/07/23 download Created with Sketch. 135.06KB
IMU Letter to Shareholders06/07/23 download Created with Sketch. 212.92KB
IMU Change of Director's Interest Notice30/06/23 download Created with Sketch. 20.97KB
IMU HER-Vaxx induced antibodies correlated with tumour reductionPRICE SENSITIVE30/06/23 download Created with Sketch. 145.8KB
IMU Imugene PD1-Vaxx patent extended to 2040PRICE SENSITIVE29/06/23 download Created with Sketch. 119.39KB
IMU Initial Director's Interest Notice23/06/23 download Created with Sketch. 141.06KB
IMU Imugene Appoints Kim Drapkin as Non-Executive Director21/06/23 download Created with Sketch. 127.89KB
IMU Imugene Advances VAXINIA MAST Trial to Next IV CohortsPRICE SENSITIVE09/06/23 download Created with Sketch. 164.13KB
IMU Imugene doses first combination patient in PD1-Vaxx trialPRICE SENSITIVE01/06/23 download Created with Sketch. 150.45KB
IMU Imugene Investor Webinar - FDA IND Clearance for onCARlytics19/05/23 download Created with Sketch. 123.53KB
IMU FDA clears Imugene IND for onCARlytics first-in-class studyPRICE SENSITIVE19/05/23 download Created with Sketch. 285.34KB
IMU onCARlytics with ARTEMIS T cells show anti-tumour activityPRICE SENSITIVE18/05/23 download Created with Sketch. 135.87KB
IMU onCARlytics with Artemis T cells abstract presented at ASGCTPRICE SENSITIVE03/05/23 download Created with Sketch. 127.55KB
IMU Phase 1 onCARlytics Trial Advances to Combination Arm
11/03/24PRICE SENSITIVE download Created with Sketch. 193.84KB
IMU Half Yearly Report and Accounts
29/02/24PRICE SENSITIVE download Created with Sketch. 1.15MB
IMU Phase 1 onCARlytics Trial Doses First Intravenous Patient
15/02/24PRICE SENSITIVE download Created with Sketch. 192.99KB
IMU Notice of change of interests of substantial holder - PH
02/02/24 download Created with Sketch. 179.34KB
IMU Change of Director's Interest Notice - PH
01/02/24 download Created with Sketch. 5.05KB
IMU Cleansing Notice
01/02/24 download Created with Sketch. 199.71KB
IMU Application for quotation of securities - IMU
01/02/24 download Created with Sketch. 26.72KB
IMU Application for quotation of securities - IMU
01/02/24 download Created with Sketch. 27.26KB
IMU Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 488.54KB
IMU Change of Director's Interest Notice x6
19/01/24 download Created with Sketch. 27.4KB
IMU Imugene CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI
19/01/24 download Created with Sketch. 191.12KB
IMU VAXINIA Phase 1 trial doses patients in higher dose cohorts
19/01/24PRICE SENSITIVE download Created with Sketch. 239.95KB
IMU Update - Notification regarding unquoted securities - IMU
18/01/24 download Created with Sketch. 40.52KB
IMU Phase 1 CF33-hNIS Study Update - Positive Early Signals
17/01/24PRICE SENSITIVE download Created with Sketch. 181.6KB
IMU Notification regarding unquoted securities - IMU
17/01/24 download Created with Sketch. 40.78KB
IMU Imugene Presentation to JPMorgan Healthcare Conference
10/01/24 download Created with Sketch. 4.33MB
IMU Imugene and NeoImmuneTech to Improve Cancer Treatments
12/12/23PRICE SENSITIVE download Created with Sketch. 193KB
IMU Imugene to Present at Annual JPMorgan Healthcare Conference
11/12/23 download Created with Sketch. 164.66KB
IMU Application for quotation of securities - IMU
06/12/23 download Created with Sketch. 26.61KB
IMU New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS
06/12/23PRICE SENSITIVE download Created with Sketch. 176.65KB
IMU Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine
06/12/23PRICE SENSITIVE download Created with Sketch. 127.27KB
IMU Results of Meeting
30/11/23 download Created with Sketch. 191.12KB
IMU AGM Presentation
30/11/23 download Created with Sketch. 3.03MB
IMU FDA Fast Track Designation Granted for VAXINIA Trial Program
28/11/23PRICE SENSITIVE download Created with Sketch. 161.6KB
IMU Investor Webinar featuring COO, Dr Glover & CMO, Dr Woodard
14/11/23 download Created with Sketch. 119.86KB
IMU Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
10/11/23PRICE SENSITIVE download Created with Sketch. 193.03KB
IMU Imugene Investor Webinar - MAST Study Update
07/11/23 download Created with Sketch. 119.17KB
IMU Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
06/11/23PRICE SENSITIVE download Created with Sketch. 179.05KB
IMU Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study
02/11/23PRICE SENSITIVE download Created with Sketch. 174.52KB
IMU Amended Annual Report
31/10/23 download Created with Sketch. 4.19MB
IMU Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 488.42KB
IMU Notice of Annual General Meeting/Proxy Form
30/10/23 download Created with Sketch. 1.05MB
IMU Imugene Phase 1 onCARlytics CD19 virus clinical trial opens
26/10/23PRICE SENSITIVE download Created with Sketch. 148.52KB
IMU Imugene B Cell & OV Platforms Featured at ESMO Congress
24/10/23PRICE SENSITIVE download Created with Sketch. 172.35KB
IMU Change of Director's Interest Notice - PH
12/10/23 download Created with Sketch. 5.59KB
IMU Change of Director's Interest Notice - LC
11/10/23 download Created with Sketch. 8.39KB
IMU Change of Director's Interest Notice - PH
04/10/23 download Created with Sketch. 5.66KB
IMU Change of Director's Interest Notice - JD
04/10/23 download Created with Sketch. 4.65KB
IMU Change of Director's Interest Notice - JE
04/10/23 download Created with Sketch. 4.71KB
IMU Change of Director's Interest Notice - KD
04/10/23 download Created with Sketch. 4.27KB
IMU Change of Director's Interest Notice - LR
04/10/23 download Created with Sketch. 4.71KB
IMU Change of Director's Interest Notice - LC
04/10/23 download Created with Sketch. 4.79KB
IMU Cleansing Notice
03/10/23 download Created with Sketch. 198.28KB
IMU Application for quotation of securities - IMU
03/10/23 download Created with Sketch. 26.47KB
IMU Distribution Schedule and Top 20
03/10/23 download Created with Sketch. 232.36KB
IMU Application for quotation of securities - IMU
03/10/23 download Created with Sketch. 30.05KB
IMU Imugene ESG Report 2023
29/09/23 download Created with Sketch. 1.4MB
IMU Appendix 4G
29/09/23 download Created with Sketch. 203.81KB
IMU Corporate Governance Statement 2023
29/09/23 download Created with Sketch. 1002.39KB
IMU Preliminary Final Report - Reporting Adjustments
29/09/23 download Created with Sketch. 146.96KB
IMU Annual Report to shareholders
29/09/23 download Created with Sketch. 4.01MB
IMU Results of Extraordinary General Meeting
28/09/23 download Created with Sketch. 176.29KB
IMU CEO Presentation to the EGM
28/09/23 download Created with Sketch. 1.39MB
IMU Azer-cel FDA IND Transferred to Imugene
28/09/23PRICE SENSITIVE download Created with Sketch. 148.99KB
IMU Application for quotation of securities - IMU
26/09/23 download Created with Sketch. 26.59KB
IMU Imugene Closes SPP Raising $18.2 million
25/09/23PRICE SENSITIVE download Created with Sketch. 118.78KB
IMU Share Purchase Plan Closing Date Extended
13/09/23 download Created with Sketch. 148.3KB
IMU Imugene PD1-Vaxx Update
12/09/23PRICE SENSITIVE download Created with Sketch. 137.53KB
IMU Imugene Receives Positive Feedback From FDA
11/09/23PRICE SENSITIVE download Created with Sketch. 170.25KB
IMU Paul Woodard, M.D. appointed as Chief Medical Officer
04/09/23 download Created with Sketch. 123.19KB
IMU VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1
04/09/23PRICE SENSITIVE download Created with Sketch. 156.91KB
IMU S&P DJI Announces September 2023 Quarterly Rebalance
01/09/23PRICE SENSITIVE download Created with Sketch. 121.59KB
IMU Imugene Appoints Dr John Byon as SVP Clinical Development
01/09/23 download Created with Sketch. 121.55KB
IMU Notice of Extraordinary General Meeting/Proxy Form
30/08/23 download Created with Sketch. 1.16MB
IMU Placement and Share Purchase Plan Update
25/08/23 download Created with Sketch. 186.13KB
IMU Prospectus
25/08/23PRICE SENSITIVE download Created with Sketch. 665.61KB
IMU Cleansing Notice
25/08/23 download Created with Sketch. 198.28KB
IMU Application for quotation of securities - IMU
25/08/23 download Created with Sketch. 26.71KB
IMU Preliminary Final Report
25/08/23PRICE SENSITIVE download Created with Sketch. 2.27MB
IMU Investor Webinar on Acquisition of License for Azer-cel
21/08/23 download Created with Sketch. 119.24KB
IMU Imugene Appoints Dr Bradley Glover as COO
21/08/23 download Created with Sketch. 142.33KB
IMU Proposed issue of securities - IMU
18/08/23 download Created with Sketch. 32.55KB
IMU Proposed issue of securities - IMU
18/08/23 download Created with Sketch. 28.6KB
IMU Imugene Capital Raising Presentation
18/08/23PRICE SENSITIVE download Created with Sketch. 2.05MB
IMU Imugene completes $35M Placement & Launches c.$30M SPP
18/08/23PRICE SENSITIVE download Created with Sketch. 267.71KB
IMU Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
16/08/23PRICE SENSITIVE download Created with Sketch. 178.46KB
IMU Trading Halt
16/08/23PRICE SENSITIVE download Created with Sketch. 211.29KB
IMU Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy
14/08/23PRICE SENSITIVE download Created with Sketch. 193.5KB
IMU Imugene CF33 Oncolytic Virus Study to be Showcased at SITC
03/08/23PRICE SENSITIVE download Created with Sketch. 134.84KB
IMU Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO
24/07/23PRICE SENSITIVE download Created with Sketch. 142.89KB
IMU Quarterly Activities/Appendix 4C Cash Flow Report
21/07/23PRICE SENSITIVE download Created with Sketch. 1.4MB
IMU Imugene Corporate Presentation
20/07/23 download Created with Sketch. 4.39MB
IMU Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
20/07/23PRICE SENSITIVE download Created with Sketch. 250.08KB
IMU Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US
19/07/23PRICE SENSITIVE download Created with Sketch. 148.79KB
IMU Imugene Appoints Dr Weitzman Interim Chief Medical Officer
18/07/23 download Created with Sketch. 120.71KB
IMU Roadshow investor webinar with Professor Yuman Fong
18/07/23 download Created with Sketch. 117.94KB
IMU Final Director's Interest Notice
07/07/23 download Created with Sketch. 7.43KB
IMU New Dose Escalation in Phase I Clinical Trial of CHECKvacc
07/07/23PRICE SENSITIVE download Created with Sketch. 135.06KB
IMU Letter to Shareholders
06/07/23 download Created with Sketch. 212.92KB
IMU Change of Director's Interest Notice
30/06/23 download Created with Sketch. 20.97KB
IMU HER-Vaxx induced antibodies correlated with tumour reduction
30/06/23PRICE SENSITIVE download Created with Sketch. 145.8KB
IMU Imugene PD1-Vaxx patent extended to 2040
29/06/23PRICE SENSITIVE download Created with Sketch. 119.39KB
IMU Initial Director's Interest Notice
23/06/23 download Created with Sketch. 141.06KB
IMU Imugene Appoints Kim Drapkin as Non-Executive Director
21/06/23 download Created with Sketch. 127.89KB
IMU Imugene Advances VAXINIA MAST Trial to Next IV Cohorts
09/06/23PRICE SENSITIVE download Created with Sketch. 164.13KB
IMU Imugene doses first combination patient in PD1-Vaxx trial
01/06/23PRICE SENSITIVE download Created with Sketch. 150.45KB
IMU Imugene Investor Webinar - FDA IND Clearance for onCARlytics
19/05/23 download Created with Sketch. 123.53KB
IMU FDA clears Imugene IND for onCARlytics first-in-class study
19/05/23PRICE SENSITIVE download Created with Sketch. 285.34KB
IMU onCARlytics with ARTEMIS T cells show anti-tumour activity
18/05/23PRICE SENSITIVE download Created with Sketch. 135.87KB
IMU onCARlytics with Artemis T cells abstract presented at ASGCT
03/05/23PRICE SENSITIVE download Created with Sketch. 127.55KB
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
161 9473412 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 259241 4
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 29/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.